BD
Behrad Derakhshan (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $108K of EWTX (2,475 sh × $43.70, as filed), executed Aug 12. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$108K
shares × price, as filed
Last traded
Aug 12
Filed Aug 14
Median ADV $64.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $408K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EWTXRecent filings
EWTXSALE
Edgewise Therapeutics, Inc.
View filing →
$108K2,475 sh × $43.70
Exec Aug 12
Filed Aug 14 · 4:53 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $300K
10,000 sh × $30.03
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET